Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Globe Life Inc. (NYSE: GL) filings with the U.S. Securities and Exchange Commission, along with AI-generated explanations to help interpret key disclosures. Globe Life is an insurance holding company focused on life and supplemental health insurance, annuities and related investment activities, and its SEC filings offer detailed insight into these operations.
Investors can review current reports on Form 8-K, where Globe Life reports material events such as quarterly earnings releases, changes to executive retirement or compensation plans and significant financing arrangements. For example, recent 8-K filings describe the company’s second and third quarter financial results, an amendment to the Supplemental Executive Retirement Plan and the creation of a pre-capitalized trust securities (P-CAP) program that provides contingent liquidity through senior notes.
Filings also document corporate governance and executive arrangements, including early retirement reduction factors and vesting rules under the SERP in connection with change-of-control protection periods. These disclosures help clarify how Globe Life structures retirement benefits and severance protections for certain executives.
Through this page, users can track debt and capital structure–related disclosures, such as facility agreements, trust arrangements and obligations tied to senior notes and pre-capitalized trust securities. These items illustrate how Globe Life manages liquidity and long-term financing in support of its insurance and investment activities.
The platform supplements raw filings with AI-powered summaries that highlight important sections, explain technical terms and distinguish between GAAP and non-GAAP measures when referenced in attached earnings materials. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while structured data views make it easier to locate information related to executive plans, financing arrangements and reported results.
Globe Life Inc. director Alice S. Cho reported acquiring company stock in an insider transaction. On 01/02/2026, she acquired 1,373 shares of Globe Life common stock at a reported price of $0, indicating an equity award rather than an open-market purchase. Following this transaction, she beneficially owned 5,877.0607 shares of Globe Life common stock in direct ownership.
The footnote explains that this total includes 37.1003 dividend right restricted stock units that were acquired in connection with restricted stock units since the date of the last report, showing that part of the position is tied to equity-based compensation that accrues dividend equivalents.
Globe Life Inc. director reports new stock grant and updated holdings. A company director acquired 1,373 shares of Globe Life common stock on 01/02/2026 at a stated price of $0, reflecting an equity-based award rather than an open-market purchase. Following this transaction, the director beneficially owns 10,102.564 shares directly and holds no shares indirectly. The reported holdings include 55.4319 dividend-right restricted stock units that were acquired in connection with restricted stock units since the prior report.
Globe Life Inc. director David A. Rodriguez reported acquiring common stock of the company. On 01/02/2026, he acquired 1,373 shares of common stock at a stated price of $0, which typically reflects an equity award rather than an open‑market purchase. Following this transaction, he beneficially owned 7,226.4852 shares of Globe Life common stock directly.
An explanatory note states that this amount includes 35.8599 dividend right restricted stock units that were acquired in connection with restricted stock units since the date of his last report.
Globe Life Inc. director Philip M. Jacobs reported acquiring 1,373 shares of common stock on 01/02/2026 at a stated price of $0, indicating a stock grant rather than an open-market purchase. Following this transaction, he beneficially owns 2,563.4851 shares directly. The filing notes that this total includes 7.4851 dividend right restricted stock units that were accrued since the prior report.
Globe Life Inc. director reports stock acquisition
A Form 4 reports that director Mark A. Blinn acquired 1,373 shares of Globe Life Inc. common stock on 01/02/2026. The transaction is coded as an acquisition and shows a price of $0 per share, indicating the shares were received without cash payment, such as through an award or similar grant. After this transaction, he beneficially owned 6,495 shares of Globe Life common stock in direct ownership. The filing indicates there are no indirectly owned shares reported.
Globe Life Inc. director Matthew J. Adams reported an acquisition of company stock. On 01/02/2026, he received 1,373 shares of Globe Life common stock in a transaction coded "A," which indicates an acquisition such as a grant or award. The shares were recorded at a price of $0, consistent with a non-cash equity grant.
After this transaction, Adams beneficially owned 2,556 shares of Globe Life common stock in direct ownership. The filing also notes that he had 0 shares held indirectly, described as "Not Applicable" for the nature of indirect beneficial ownership. The form is filed for one reporting person and reflects his status as a director of Globe Life Inc.
Globe Life Inc. insider Frank M. Svoboda, who serves as Co-Chairman, CEO and Director, reported changes in his indirect ownership of the company’s common stock. On 12/19/2025, 26,425 shares were transferred at a price of $0 from a family trust, where the holdings are now reported as 108,473 shares held indirectly, to his spouse's irrevocable trust, which now holds 26,425 shares indirectly. The filing also reports 35,868 shares of common stock and 1,947.384 shares held indirectly through a 401(k) plan following the reported transactions.
Globe Life Inc. reported insider stock transactions by Co-Chairman, CEO and Director Frank M. Svoboda on December 16, 2025. He exercised an employee stock option to acquire 12,500 shares of common stock at an exercise price of $82.56 per share, then sold portions of those shares on the same day.
The reported sales totaled 6,579 shares at a price shown as $140.2742 per share, with actual sale prices ranging from $139.65 to $140.64, and an additional 2,800 shares at $140.7887 per share, with prices ranging from $140.65 to $141.03. After these transactions, he directly owned 35,868 Globe Life common shares, plus 134,898 shares held through a family trust and 1,947.384 shares through a 401(k) plan.
Globe Life Inc. executive Michael Shane Henrie, SVP & Chief Accounting Officer, reported an option exercise and share sale on 07/29/2025. He exercised employee stock options for 3,250 shares of common stock at $103.23 per share, then sold 3,250 shares at a weighted average price of $139.7526, with individual trades between $139.67 and $139.90.
After these transactions, he directly owned 3,040 Globe Life shares and held an additional 152.182 shares indirectly through a 401(k) plan. The amended report also corrects the amount of underlying securities shown for the employee stock option in Table II, while noting that the original report was filed on time.
Globe Life Inc. officer Michael Shane Henrie, the company’s SVP and Chief Accounting Officer, reported exercising stock options and selling common shares on 12/12/2025.
He exercised 3,065 employee stock options at an exercise price of $120.49 per share and sold 3,065 shares of Globe Life common stock at a weighted average price of $139.0997 per share, with sale prices ranging from $138.87 to $139.325. After these transactions, he directly owned 3,040 shares of common stock and indirectly held 154.904 shares through a 401(k) plan. The Form 4 also lists 3,065 employee stock options expiring on 02/22/2030, which were first exercisable as to 50% of the shares on 02/22/2025 and the remaining 50% on 02/22/2026.